BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16341841)

  • 1. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.
    Guzder RN; Gatling W; Mullee MA; Byrne CD
    Diabetologia; 2006 Jan; 49(1):49-55. PubMed ID: 16341841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
    Bonora E; Targher G; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Gemma L; Santi L; Bonadonna RC; Muggeo M
    Diabet Med; 2004 Jan; 21(1):52-8. PubMed ID: 14706054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.
    Hajat C; Shather Z
    Diabetes Res Clin Pract; 2012 Dec; 98(3):481-6. PubMed ID: 23140808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.
    Wilson PW; D'Agostino RB; Parise H; Sullivan L; Meigs JB
    Circulation; 2005 Nov; 112(20):3066-72. PubMed ID: 16275870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
    Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
    Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
    Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M
    Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Dulbecco CA; Reaven GM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):366-373. PubMed ID: 28254109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
    de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
    Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
    Targher G; Bertolini L; Poli F; Rodella S; Scala L; Tessari R; Zenari L; Falezza G
    Diabetes; 2005 Dec; 54(12):3541-6. PubMed ID: 16306373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
    Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetologia; 2006 Jan; 49(1):56-65. PubMed ID: 16365726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.